封面
市場調查報告書
商品編碼
1392329

全球灌注系統市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢和預測

Global Perfusion System Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: | 出版商: Value Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

全球灌注系統市場需求預計將從 2022 年的 42.4 億美元達到 2030 年近 76.8 億美元的市場規模,2023-2030 年研究期間CAGR為 6.82%。

灌注系統是用於在手術期間將含氧血液輸送到身體的裝置。灌注系統用於心臟手術,灌注專家透過使用人工血泵向患者註入血液,在心臟外科醫生手術時取代心臟的功能。灌注系統也用於化療,以治療手臂或腿部的黑色素瘤。灌注系統技術暫時停止肢體中的血流,將抗癌藥物直接注射到肢體的血液中。器官移植手術使用灌注系統,因為它們透過將血液泵送到全身來幫助在手術過程中替代器官的功能。

市場動態:

隨著全球心血管和呼吸系統疾病盛行率的不斷上升,全球灌注系統市場可能會成長。此外,飲食不當、吸煙和飲酒也會導致器官衰竭,這導致了對有效灌注系統的需求。此外,灌注系統市場也受到製藥和生物技術產業顯著成長的推動。此外,技術發展為未來幾年的市場成長提供了重大機會。然而,發展中國家對灌注系統缺乏認知可能會限制該市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球灌注系統市場的各個細分市場進行了包容性評估。灌注系統產業的成長和趨勢為本研究提供了整體方法。

區域分析:

本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲灌注系統市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。灌注系統市場的主要參與者包括 Getinge AB、Medtronic plc、LivaNova、Terumo Corporation、Nipro Corporation、XENIOS AG、Repligen Corporation、Spectrum Laboratories Inc.、Merck KGaA、Harvard Bioscience Inc.、ALA Scientific Instruments, Inc.、Lifeline科學公司、XVIVO 灌注公司。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第 1 章:前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:灌注系統 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 市場吸引力分析:依應用分類
    • 市場吸引力分析:按地區

第 4 章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章:COVID-19 爆發的影響分析

第 6 章:全球灌注系統市場分析:依應用分類

  • 概述:按應用
  • 歷史和預測數據
  • 分析:按應用
  • 心肺灌注系統(制氧機、心肺機、灌注幫浦、插管、監護系統等)
  • 細胞灌流系統(生物反應器灌流系統、微流控灌流系統、重力/壓力驅動灌流系統、小型哺乳動物器官灌流系統)
  • 離體器官灌注系統(低溫、常溫)

第 7 章:全球灌注系統市場分析:以地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章:灌注系統公司的競爭格局

  • 灌注系統市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章:公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Getinge AB
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Medtronic plc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • LivaNova
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Terumo Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Nipro Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • XENIOS AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Repligen Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Spectrum Laboratories Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Merck KGaA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Harvard Bioscience Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • ALA Scientific Instruments Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Lifeline Scientific Inc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • XVIVO Perfusion AB
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中,財務詳細資訊和近期發展視情況而定,或者如果是私人公司,則可能不包括在內

Product Code: VMR11218522

The global demand for Perfusion System Market is presumed to reach the market size of nearly USD 7.68 BN by 2030 from USD 4.24 BN in 2022 with a CAGR of 6.82% under the study period 2023 - 2030.

Perfusion system is a device used to deliver oxygenated blood to the body during surgery. Perfusion systems are used in heart surgeries where perfusion experts thrust patients' blood by employing artificial blood pumps, which replace the heart's function while the cardiac surgeon operates. Perfusion systems are also used in chemotherapy for the treatment of melanoma present in the arm or legs. Perfusion system technique temporarily stops blood flow in the limb, allowing anticancer drugs to be injected directly into the limb's blood. Organ transplant surgeries use perfusion systems as they help replace the organ's function during the operation by pumping blood throughout the body.

MARKET DYNAMICS:

The global perfusion system market is likely to grow with the increasing prevalence of cardiovascular and respiratory diseases across the globe. Moreover, improper diet, smoking and consumption of alcohol also leads to organ failure, which has led to the demand for effective perfusion systems. Furthermore, the perfusion systems market is also driven by the significant growth of the pharmaceutical and biotechnology industries. Additionally, technological development holds a significant opportunity for market growth in the coming years. However, a lack of awareness regarding perfusion systems in developing countries can limit the growth of this market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of perfusion system. The growth and trends of perfusion system industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the perfusion system market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

  • Cardiopulmonary Perfusion System (Oxygenators, Heart-Lung Machine, Perfusion Pumps, Cannula, Monitoring System, Others)
  • Cell Perfusion System (Bioreactor Perfusion System, Microfluidic Perfusion System, Gravity/Pressure-Driven Perfusion System, Small Mammal Organ Perfusion System)
  • Ex-Vivo Organ Perfusion System (Hypothermic, Normothermic)

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Perfusion System market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Perfusion System market include Getinge AB, Medtronic plc, LivaNova, Terumo Corporation, Nipro Corporation, XENIOS AG, Repligen Corporation, Spectrum Laboratories Inc., Merck KGaA, Harvard Bioscience Inc., ALA Scientific Instruments, Inc., Lifeline Scientific Inc, XVIVO Perfusion AB. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PERFUSION SYSTEM - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Application
    • 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PERFUSION SYSTEM MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Cardiopulmonary Perfusion System (Oxygenators, Heart-lung Machine, Perfusion Pumps, Cannula, Monitoring System, Others) Historic and Forecast Sales by Regions
  • 6.5 Cell Perfusion System (Bioreactor Perfusion System, Microfluidic Perfusion System, Gravity/Pressure-driven Perfusion System, Small Mammal Organ Perfusion System) Historic and Forecast Sales by Regions
  • 6.6 Ex-vivo Organ Perfusion System (Hypothermic, Normothermic) Historic and Forecast Sales by Regions

7 . GLOBAL PERFUSION SYSTEM MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE PERFUSION SYSTEM COMPANIES

  • 8.1. Perfusion System Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF PERFUSION SYSTEM INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Getinge AB
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Medtronic plc
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. LivaNova
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Terumo Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Nipro Corporation
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. XENIOS AG
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Repligen Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Spectrum Laboratories Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Merck KGaA
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Harvard Bioscience Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. ALA Scientific Instruments Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Lifeline Scientific Inc
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. XVIVO Perfusion AB
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Application (USD MN)
  • Cardiopulmonary Perfusion System (Oxygenators, Heart-lung Machine, Perfusion Pumps, Cannula, Monitoring System, Others) Market Sales by Geography (USD MN)
  • Cell Perfusion System (Bioreactor Perfusion System, Microfluidic Perfusion System, Gravity/Pressure-driven Perfusion System, Small Mammal Organ Perfusion System) Market Sales by Geography (USD MN)
  • Ex-vivo Organ Perfusion System (Hypothermic, Normothermic) Market Sales by Geography (USD MN)
  • Global Perfusion System Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Perfusion System Report
  • Market Research Process
  • Market Research Methodology
  • Global Perfusion System Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Application (USD MN)
  • Cardiopulmonary Perfusion System (Oxygenators, Heart-lung Machine, Perfusion Pumps, Cannula, Monitoring System, Others) Market Sales by Geography (USD MN)
  • Cell Perfusion System (Bioreactor Perfusion System, Microfluidic Perfusion System, Gravity/Pressure-driven Perfusion System, Small Mammal Organ Perfusion System) Market Sales by Geography (USD MN)
  • Ex-vivo Organ Perfusion System (Hypothermic, Normothermic) Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.